See also this year's filing and all EDGAR filings for this company.
PDF Report 0001863127_2022_Tyra_Biosciences_Inc.pdf
Logs
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001863127')"} |
Graph
Absolute values for 0001863127, Tyra Biosciences Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 304,057,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,027,000 |
| 3 | remainder_Assets | 1,617,000 |
| 4 | LiabilitiesCurrent | 3,616,000 |
| 5 | LiabilitiesNoncurrent | 1,348,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 5,652,000 |
| 9 | ResearchAndDevelopmentExpense | 20,636,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -6,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 306,701,000 |
| 1 | Liabilities | 4,964,000 |
| 2 | Expenses | 26,288,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 301,737,000 |
| 5 | NetIncome | -26,294,000 |
| 6 | ComprehensiveNetIncome | -26,294,000 |
| 7 | BaseVar | 168,979,500 |
| 8 | EconomicCapitalRatio | 3.16 |